Myeloid Therapeutics, Inc. has 7 H-1B filings in Massachusetts with $90,714 avg salary. 100% approval rate.
Myeloid Therapeutics, Inc. has filed 7 H-1B petitions in Massachusetts, with an average salary of $91k. The most common roles are Research Associate, Discovery Research (29%), Senior Research Associate, Molecular Biology (29%), Principal Scientist, Discovery Research (14%). 100% of petitions were certified, with an average processing time of 23 days. Salaries range from $65k to $140k. 57% of positions are for new employment.
| Total Filings | 7 |
| Approval Rate | 100% |
| Average Salary | $90,714 |
| Median Salary | $90,000 |
| 25th Percentile | $65,000 |
| 75th Percentile | $100,000 |
| Minimum Salary | $65,000 |
| Maximum Salary | $140,000 |
| Percentile | Salary |
|---|---|
| 10th | $65k |
| 25th | $65k |
| 50th (Median) | $90k |
| 75th | $100k |
| 90th | $140k |
Based on 7 salary records. Range: $65k – $140k.
100% of filings offer salaries above the prevailing wage, with an average premium of 4.9%. The average prevailing wage is $86k (based on 7 filings with prevailing wage data).
Average processing time is 23 days (median: 7 days). Fastest: 7 days, slowest: 118 days. Based on 7 filings.
57% of filings are for new positions, while 0% are for continued employment (7 filings with data).
Average contract duration: 36 months (median: 36 months), based on 7 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 7 |
| Job Title | Filings |
|---|---|
| Research Associate, Discovery Research | 2 |
| Senior Research Associate, Molecular Biology | 2 |
| Principal Scientist, Discovery Research | 1 |
| Engineer, Process Development | 1 |
| Sr. Research Associate, Analytical Development | 1 |
Myeloid Therapeutics, Inc. has 7 H-1B filings in Massachusetts in our database of DOL public records.
The average H-1B salary at Myeloid Therapeutics, Inc. in Massachusetts is $90,714, with a median of $90,000. Salaries range from $65,000 to $140,000.
Myeloid Therapeutics, Inc.'s H-1B approval rate in Massachusetts is 100% based on 7 DOL filings.